Please check your internet connection and try again.
# Sompraz HP (Pantoprazole Sodium)
## Overview
Pantoprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion.
## Primary Indications
* Gastroesophageal reflux disease (GERD) - erosive esophagitis healing and maintenance, symptomatic GERD.
* Duoodenal ulcers.
* Gastric ulcers.
* Pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome).
## Adult Dosing
* **Erosive esophagitis healing:** 40 mg once daily for 4-8 weeks.
* **GERD (symptomatic):** 20 mg once daily for up to 4 weeks.
* **Maintenance of healing erosive esophagitis:** 40 mg once daily.
* **Duodenal/Gastric Ulcers:** 40 mg once daily for 2-4 weeks.
* **Pathological hypersecretory conditions:** Start with 40 mg twice daily. Doses may be increased to 80 mg twice daily or higher.
## Pediatric Dosing
* **GERD (erosive esophagitis):**
* 1-5 years: 10 mg once daily for up to 8 weeks.
* 6-11 years: 20 mg once daily for up to 8 weeks.
* 12-17 years: 40 mg once daily for up to 8 weeks.
## Dose Adjustments
* **Hepatic Impairment:** Maximum dose is 20 mg once daily.
* **Renal Impairment:** No dose adjustment needed.
## Contraindications
* Known hypersensitivity to pantoprazole or any component of the formulation.
## Adverse Effects
* **Common:** Headache, diarrhea, nausea, abdominal pain, vomiting, dizziness.
* **Serious:** *Clostridium difficile*-associated diarrhea, bone fractures (hip, wrist, spine) with long-term use, hypomagnesemia, vitamin B12 deficiency, potential for increased risk of pneumonia.
## Key Drug Interactions
* **Antiretrovirals:** May decrease absorption of drugs like atazanavir, nelfinavir.
* **Methotrexate:** PPIs may increase methotrexate levels.
* **Warfarin:** Increased risk of bleeding.
* **Clopidogrel:** Potential for reduced efficacy.
## Monitoring
* Magnesium levels, especially with prolonged therapy (>3 months).
* Bone mineral density in patients at risk for osteoporosis.
* Signs and symptoms of *C. difficile* infection.
* Vitamin B12 levels with long-term therapy.
## Clinical Pearls
* Administer 30-60 minutes before a meal.
* Do not crush or chew delayed-release tablets.
* Long-term use is associated with increased risks of fractures, hypomagnesemia, and vitamin B12 deficiency. Consider periodic reassessment of the need for continued therapy.
***
*Disclaimer: This information is intended for healthcare professionals. Always consult the current prescribing information and your institution's protocols for definitive guidance.*
